Literature DB >> 25283730

Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage.

Qin Lei1, Shu Li, Ruibin Zheng, Ke Xu, Songbai Li.   

Abstract

INTRODUCTION: Cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) often leads to poor outcomes in SAH patients. Overexpression of endothelin-1 (ET-1) could contribute to the development of CVS. The purpose of this study was to investigate cerebral microcirculation by whole-brain perfusion CT scan and ET-1 expression following SAH.
METHODS: SAH was induced in rabbits. Cerebral blood flow (CBF), cerebral blood volume (CBV), time to peak (TTP), and mean transit time (MTT) were measured with CT perfusion techniques at days 1, 4, 7, and 14 following SAH. Expression of ET-1 was determined by ELISA accordingly. Histological sections of the brain tissue were also examined.
RESULTS: Whole-brain perfusion showed that CBV and TTP increased at day 4 and maintained elevated rate until day 14. MTT increased at day 4, peaked at day 7, and then decreased at day 14. CBV of the occipital lobe was greater than that in the frontal and parietal lobes at day 4. CBF of the occipital lobe increased significantly compared to that of other lobes at day 7. ET-1 expression in the SAH group was significantly greater than that in the control at various time points. Moreover, ET-1 levels were positively correlated with MTT value.
CONCLUSION: CTP detects changes in cerebral microcirculation following SAH. Microcirculation of each lobe was different and could be quantified to identify high-risk areas of cerebral ischemia. ET-1 expression was significantly increased and was correlated with MTT as well, suggesting that ET-1 influences cerebral microcirculation following SAH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25283730     DOI: 10.1007/s00234-014-1435-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  31 in total

1.  Raised plasma endothelin in aneurysmal subarachnoid haemorrhage.

Authors:  H Masaoka; R Suzuki; Y Hirata; T Emori; F Marumo; K Hirakawa
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

2.  Comparison of CT perfusion and digital subtraction angiography in the evaluation of delayed cerebral ischemia.

Authors:  Ronan P Killeen; Alvin I Mushlin; Carl E Johnson; Joseph P Comunale; Apostolos John Tsiouris; Holly Delaney; Allison Dunning; Pina C Sanelli
Journal:  Acad Radiol       Date:  2011-06-11       Impact factor: 3.173

Review 3.  Palatal myoclonus and denervation supersensitivity in the central nervous system.

Authors:  F Matsuo; E T Ajax
Journal:  Ann Neurol       Date:  1979-01       Impact factor: 10.422

4.  Balloon angioplasty for the treatment of vasospasm: results of first 50 cases.

Authors:  J M Eskridge; W McAuliffe; J K Song; A V Deliganis; D W Newell; D H Lewis; M R Mayberg; H R Winn
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

5.  A low mortality rat model to assess delayed cerebral vasospasm after experimental subarachnoid hemorrhage.

Authors:  Rahul V Dudhani; Michele Kyle; Christina Dedeo; Margaret Riordan; Eric M Deshaies
Journal:  J Vis Exp       Date:  2013-01-17       Impact factor: 1.355

6.  Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome.

Authors:  Maria E Baldwin; R Loch Macdonald; Dezheng Huo; Roberta L Novakovic; Roberta L Novakovia; Fernando D Goldenberg; Jeffrey I Frank; Axel J Rosengart
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

7.  Inhibition of protein kinase C signal reduces ET receptor expression and basilar vasospasm after subarachnoid hemorrhage in rats.

Authors:  Leitao Sun; Wensheng Zhang; Xiaohong Wang; Jinning Song; Min Li
Journal:  J Integr Neurosci       Date:  2012-12-28       Impact factor: 2.117

8.  CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage.

Authors:  A M Laslo; J D Eastwood; P Pakkiri; F Chen; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-26       Impact factor: 3.825

Review 9.  A review of hemoglobin and the pathogenesis of cerebral vasospasm.

Authors:  R L Macdonald; B K Weir
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  5 in total

1.  Aneurysmal subarachnoid hemorrhage--status quo and perspective.

Authors:  Nima Etminan
Journal:  Transl Stroke Res       Date:  2015-04-11       Impact factor: 6.829

2.  The Protective Effects of Zeaxanthin on Amyloid-β Peptide 1-42-Induced Impairment of Learning and Memory Ability in Rats.

Authors:  Xiaoying Li; Ping Zhang; Hongrui Li; Huiyan Yu; Yuandi Xi
Journal:  Front Behav Neurosci       Date:  2022-06-23       Impact factor: 3.617

3.  Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage.

Authors:  Nian-Sheng Lai; Jia-Qi Zhang; Fei-Yun Qin; Bin Sheng; Xing-Gen Fang; Zhen-Bao Li
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

Review 4.  Targeting brain microvascular endothelial cells: a therapeutic approach to neuroprotection against stroke.

Authors:  Qi-Jin Yu; Hong Tao; Xin Wang; Ming-Chang Li
Journal:  Neural Regen Res       Date:  2015-11       Impact factor: 5.135

Review 5.  The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.

Authors:  Stefan Wanderer; Basil E Grüter; Fabio Strange; Sivani Sivanrupan; Stefano Di Santo; Hans Rudolf Widmer; Javier Fandino; Serge Marbacher; Lukas Andereggen
Journal:  Brain Sci       Date:  2020-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.